The Role of Prolactin as a Disease Activity Indicator in Some Rheumatic Diseases
Background: Autoimmune rheumatic diseases, including rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), and scleroderma, predominantly affect women and are characterized by systemic inflammation, leading to organ failure. Prolactin (PRL), a hormone produced by the pituitary gland and lym...
Saved in:
Main Authors: | Mohamed Ismail Abdelkarem, HM Fayed, Wael Abd El-Mohsen Abady, Eman Abulhagag Mohammed Mahmoud |
---|---|
Format: | Article |
Language: | English |
Published: |
South Valley University, Faculty of Medicine
2025-07-01
|
Series: | SVU - International Journal of Medical Sciences |
Subjects: | |
Online Access: | https://svuijm.journals.ekb.eg/article_382169.html |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
From Multimorbidity to Network Medicine in Patients with Rheumatic Diseases
by: Winston Gilcrease, et al.
Published: (2024-11-01) -
The Role of IL-37 as an Anti-Inflammatory Biomarker in some Iraqi Rheumatoid Arthritis Patients and Its Correlation with DAS28
by: Sattar Brissm Hassan, et al.
Published: (2022-11-01) -
Impact of anxiety and depression on disease activity and quality of life in patients with lupus nephritis
by: Ritambra Dadwal, et al.
Published: (2023-04-01) -
Cell-free DNA: a metabolic byproduct with diagnostic and prognostic potential in rheumatic disorders
by: Fancheng Liu, et al.
Published: (2025-02-01) -
Beyond the microbiome: unraveling gut dysbiosis and its impact on systemic lupus erythematosus
by: Yara Safwat Roshdy, et al.
Published: (2025-12-01)